Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04910685
Title (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Blueprint Medicines Corporation
Age Groups: adult | child | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL | AUT | AUS

Additional content available in CKB BOOST